Daiwa Securities Group’s Endocyte, Inc. Common Stock ECYT Stock Holding History

Daiwa Securities Group’s Portfolio ECYT Stock Details ECYT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-265	Closed	-$5K	–	1226
2018 Q3	$5K	Hold	265	–	–	﹤0.01%	1087
2018 Q2	$4K	Hold	265	–	–	﹤0.01%	1116
2018 Q1	$2K	Buy	+265	New	+$1.46K	﹤0.01%	1143

Other funds holding ECYT

OTC

Opera Trading Capital Paris, France $419M AUM 0.58% 1-Year Est. Return

Claro Advisors Boston, Massachusetts $953M AUM 24.79% 1-Year Est. Return

Daiwa Securities Group's ECYT Position: Q4 2018 in Review

Daiwa Securities Group sold out of Endocyte, Inc. Common Stock (ECYT) in Q4 2018, closing a stake of 265 shares — an estimated $5K sold.

Daiwa Securities Group first reported a position in ECYT in Q1 2018 and held it in 3 quarters. The position peaked at $5K in Q3 2018. 2 funds tracked by Wall St. Rank hold ECYT as of Q4 2018.

Daiwa Securities Group reported no remaining Endocyte, Inc. Common Stock position as of Q4 2018 after selling out during the quarter.
Daiwa Securities Group sold 265 Endocyte, Inc. Common Stock shares in Q4 2018, an estimated $5K.
Daiwa Securities Group first reported a position in Endocyte, Inc. Common Stock in Q1 2018 and held it in 3 quarters.
Daiwa Securities Group's Endocyte, Inc. Common Stock position peaked at $5K in Q3 2018.
2 funds tracked by Wall St. Rank held Endocyte, Inc. Common Stock as of Q4 2018.

Based on Daiwa Securities Group's 13F filing for Q4 2018, filed 5 Feb 2019.